emerging glp-1 gip obesity treatments 2025 Harnessing Receptor Agonists for Treatment: Prospects and Obstacles on the Horizon GLP-1 Medications for Weight Loss:

For years, we measured success by how much people consumed

Cigna will stop covering GLP-1 weight-loss drugs such as Wegovy and Zepbound for its employees starting July 1, signaling that even major healthcare companies are struggling with the high cost of these medications

The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

A girl named Sam is not playing

Learn what FDA data shows about neurological side effects, when to contact your doctor, and how to manage symptoms during GLP-1 treatment.

Rare disorders and disease progression were not examined